Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00672373Phase 3Completed
A Phase 3 trial of Yikangning in tardive dyskinesia (TD), sponsored by Peking University Huilongguan Hospital. Started Dec 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00672373.